title: Sef is a negative regulator of fiber cell differentiation in the ocular lens.
abstract: Growth factor signaling, mediated via receptor tyrosine kinases (RTKs), needs to be tightly regulated in many developmental systems to ensure a physiologically appropriate biological outcome. At one level this regulation may involve spatially and temporally ordered patterns of expression of specific RTK signaling antagonists, such as Sef (similar expression to fgfs). Growth factors, notably FGFs, play important roles in development of the vertebrate ocular lens. FGF induces lens cell proliferation and differentiation at progressively higher concentrations and there is compelling evidence that a gradient of FGF signaling in the eye determines lens polarity and growth patterns. We have recently identified the presence of Sef in the lens, with strongest expression in the epithelial cells. Given the important role for FGFs in lens developmental biology, we employed transgenic mouse strategies to determine if Sef could be involved in regulating lens cell behaviour. Over-expressing Sef specifically in the lens of transgenic mice led to impaired lens and eye development that resulted in microphthalmia. Sef inhibited primary lens fiber cell elongation and differentiation, as well as increased apoptosis, consistent with a block in FGFR-mediated signaling during lens morphogenesis. These results are consistent with growth factor antagonists, such as Sef, being important negative regulators of growth factor signaling. Moreover, the lens provides a useful paradigm as to how opposing gradients of a growth factor and its antagonist could work together to determine and stabilise tissue patterning during development and growth.
authors.affiliation: Save Sight Institute, University of Sydney, NSW, Australia.
authors.forename: Peter
authors.initials: P
authors.lastname: Newitt
authors.forename: Jessica
authors.initials: J
authors.lastname: Boros
authors.forename: Bhavani P
authors.initials: BP
authors.lastname: Madakashira
authors.forename: Michael L
authors.initials: ML
authors.lastname: Robinson
authors.forename: Lixing W
authors.initials: LW
authors.lastname: Reneker
authors.forename: John W
authors.initials: JW
authors.lastname: McAvoy
authors.forename: Frank J
authors.initials: FJ
authors.lastname: Lovicu
mesh_terms: D000818:Animals; D017209:Apoptosis; D015153:Blotting, Western; D002454:Cell Differentiation; D004622:Embryo, Mammalian / Q000166:cytology* / Q000378:metabolism; D004847:Epithelial Cells / Q000378:metabolism; D005260:Female; D005346:Fibroblast Growth Factors / Q000235:genetics / Q000378:metabolism; D006801:Humans; D020287:In Situ Nick-End Labeling; D007908:Lens, Crystalline / Q000166:cytology* / Q000378:metabolism; D008297:Male; D008565:Membrane Proteins / Q000502:physiology*; D051379:Mice; D008822:Mice, Transgenic; D008850:Microphthalmos / Q000378:metabolism / Q000473:pathology; D011401:Promoter Regions, Genetic; D012333:RNA, Messenger / Q000235:genetics; D017468:Receptors, Fibroblast Growth Factor / Q000502:physiology; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015398:Signal Transduction; D038202:alpha-Crystallin A Chain / Q000235:genetics
chemical_list: D008565:Membrane Proteins; D012333:RNA, Messenger; D017468:Receptors, Fibroblast Growth Factor; C469338:Sef protein, mouse; D038202:alpha-Crystallin A Chain; D005346:Fibroblast Growth Factors